Patent Assignment
Reel/Frame 025168/0650
Assignment of Assignor's Interest
Recorded: 2010-10-20
Pages: 8
Assignors
WANG, BING
Executed: 2010-10-11
CHU, DANIEL
Executed: 2010-10-13
LIU, YONGBO
Executed: 2010-10-09
JIANG, QUAN
Executed: 2010-10-09
LU, LEI
Executed: 2010-10-09
Assignee
BIOMARIN PHARMACEUTICAL INC
105 DIGITAL DRIVE, NOVATO, CALIFORNIA, 94949
Covered Property
(1)
Processes of Synthesizing Dihydropyridophthalazinone Derivatives
Application:
61/302,457 →
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Corrective Assignment to Correct the Assignee from Biomarin Pharmaceutical Inc. to Lead Therapeutics,Inc. Previously Recorded on Reel 025168 Frame 0650. Assignor(S) Hereby Confirms the Assignment.
Jan 11, 2011
From: WANG, BING; CHU, DANIEL; LIU, YONGBO; JIANG, QUAN
To: LEAD THERAPEUTICS, INC.
Reel/Frame 025764/0684 →
Assignment of Assignor's Interest
Feb 1, 2011
From: LEAD THERAPEUTICS, INC.
To: BIOMARIN PHARMACEUTICAL INC.
Reel/Frame 025728/0451 →
Security Interest
Oct 23, 2015
From: MEDIVATION, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 036866/0635 →
Assignment of Assignor's Interest
Mar 30, 2016
From: BIOMARIN PHARMACEUTICAL INC.
To: MEDIVATION, INC.
Reel/Frame 038137/0906 →
Assignment of Assignor's Interest
Mar 30, 2016
From: MEDIVATION, INC.
To: MEDIVATION TECHNOLOGIES, INC.
Reel/Frame 038138/0043 →
Release of Security Interest
Sep 28, 2016
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: MEDIVATION, INC.
Reel/Frame 039873/0219 →